Insider · CIK 0001774294
Timothy Maness
Files at APTN (ADAPTIN BIO, INC.). First filing -, latest -.
Timothy Maness files SEC Form 4 as CFO at APTN (ADAPTIN BIO, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Timothy Maness has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | APTN ADAPTIN BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +192,231 | $0.00 | $0 | 192,231 | Sep 10, 2025 |
Questions about Timothy Maness
Answered from the filings on this page, as of the latest one.
Is Timothy Maness buying or selling?
Timothy Maness has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Timothy Maness's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy Maness has 0.
Where does Timothy Maness file Form 4?
Timothy Maness has filed Form 4 at APTN (ADAPTIN BIO, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.